PharmaLinea joins ANJAC Health & Beauty through acquisition

In a recent press release, PharmaLinea, unveiled that ANJAC Health & Beauty, a French industrial group, has acquired the company. The provider of clinically supported private label food supplements will now join ANJAC Health & Beauty’s 17 complementary companies that consist of R&D, as well as capabilities in production in sectors that varies from personal care, health, food supplements, and beauty. With the acquisition, PharmaLinea will be able to grow and invest in new technologies, partners, and other innovations.

PharmaLinea and HCG have grown through vertical integration. As mentioned in the press release, HCG began as a single ingredient distribution company before growing into a company with involvement at the international level in the B2B nutraceutical industry and is active in more than 40 markets throughout the world. HCG works with three sister companies that use a vertically integrated model that helps manage the chain of ingredients as they become finished products. They operate via three complementary entities, according to the press release:

• Hermes Consilium – a creator and distributor of high-quality, branded ingredients for nutritional products.
• PharmaLinea - an expert in the development of clinically supported private label food supplements, backed by clinical studies, patented ingredients and technologies, and offering scientific and marketing consulting services to clients.
• ErgoPharma – a state-of-the-art production unit for manufacturing, ensuring industrial performance and full traceability.

With the partnership between PharmaLinea and ANJAC Health & Beauty will allow for new opportunities for scientific research, more comprehensive service to client brands, and further product innovation. Through the acquisition, the press release mentioned that “PharmaLinea will retain its distinctive identity and dedication to the principles that have defined its success. It will continue to operate as a trusted partner to nutraceutical brands worldwide, while benefiting from ANJAC’s extensive infrastructure, cross-sector expertise, and R&D resources. As part of the ANJAC Group, PharmaLinea will be able to accelerate the development of high-value, clinically supported concepts and bring forward new formats and solutions that meet the evolving needs of health-conscious consumers.”

“PharmaLinea and Health Chain Group was founded with a simple yet ambitious goal: to bring more science, integrity, and trust to the nutraceutical industry. Seeing that vision grow into a group recognized across the world fills me with pride and gratitude,” said Blaž Gorjup, Chairman & Founder of PharmaLinea. “Joining forces with ANJAC will allow HCG to reach even higher while staying true to its values. It’s because of this strong foundation and bright outlook that I chose to remain a minority shareholder and continue to be available to the company as it moves forward. My sincere thanks go to everyone who has contributed to this journey.”

“This marks an incredibly exciting new chapter for PharmaLinea. Becoming part of ANJAC Health & Beauty represents both a great milestone and a strong confirmation of how far we’ve come — the culmination of many years of hard work in establishing our company, our processes, our network, and our product pipeline,” expressed Anton Oražem, CEO of PharmaLinea. “We are truly proud to join such a renowned group that shares the same values, entrepreneurial DNA, and long-term vision for the future. With ANJAC’s extensive network across the health and beauty industries, PharmaLinea will gain access to new technologies, new innovation possibilities, and new partners — all of which will further strengthen our ability to deliver premium, clinically substantiated supplement solutions to our clients. This partnership opens an era of extraordinary opportunity. It will give wings to PharmaLinea’s story, while at the same time complementing and completing the offering that ANJAC provides to its partners worldwide. We are excited about the journey ahead and the value this collaboration will bring to both organizations.”

Aurélien Chaufour, President of the ANJAC Group commented in the press release, “We are delighted to welcome HCG to the ANJAC Group. This partnership reflects our strong ambitions in the health and pharma segment, our strategy in clinically backed food and nutraceuticals solutions and the continued acceleration of our international growth. We share with HCG a common vision: delivering innovative, high-performance solutions with a premium level of service recognized by our clients.”